Lv1
34 积分 2021-11-25 加入
Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies
13天前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
18天前
已完结
Tenecteplase versus alteplase before mechanical thrombectomy: experience from a US healthcare system undergoing a system-wide transition of primary thrombolytic
21天前
已完结
Intravenous tenecteplase for acute ischaemic stroke within 24 h due to basilar artery occlusion
1个月前
已关闭
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
1个月前
已完结
Alteplase 4.5 to 24 Hours After Acute Ischemic Stroke
2个月前
已关闭
Mineralocorticoid Receptor Antagonist Combined with SGLT2 Inhibitor versus SGLT2 Inhibitor Alone in Chronic Kidney Disease: A Meta-Analysis of Randomized Trials
2个月前
已关闭
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
2个月前
已完结
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
3个月前
已完结
Combination therapy for kidney disease in people with diabetes mellitus
3个月前
已完结
皖公网安备34019202002308
